[[-2] proPSA: A Novel Marker of Prostate Cancer].

Over the decades, prostate-specific antigen (PSA) has contributed to the early detection of and screening for prostate cancer (PCa). However, PSA is now in the spotlight due to issues of overdetection and subsequent overtreatment of PCa, causing a serious drawback in PSA-based screening. The challenge of a PSA assay for PCa detection is that the sensitivity is high, whereas the specificity is relatively low.

Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen.

An urgent need exists to develop a more sophisticated screening system in order to improve diagnostic accuracy of clinically significant cancer and also to reduce the drawbacks of prostate-specific antigen (PSA) screening including overdetection and overtreatment. The most promising next-generation PSA test, which can improve the management of prostate cancer, may be proenzyme PSA (proPSA) or precursor PSA (pPSA). proPSA has pro-leader peptide sequences of seven or less amino acids and previous studies demonstrated that [-2]proPSA, which contains only a 2-amino-acid propeptide leader, could be more useful not only to distinguish between men with and without cancer, but also between tumors with aggressive features with performance exceeding other classical PSA-related indices including ratio of free PSA to total PSA (%f-PSA) and PSA density.

Utility of a panel of sera for the alignment of test results in the worldwide multicenter study on reference values.

Background: In a planned International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) worldwide study on reference intervals (RIs), a common panel of serum samples is to be measured by laboratories from different countries, and test results are to be compared through conversion using linear regression analysis. This report presents a validation study that was conducted in collaboration with four laboratories.

Methods: A panel composed of 80 sera was prepared from healthy individuals, and 45 commonly tested analytes (general chemistry, tumor markers, and hormones) were measured on two occasions 1 week apart in each laboratory.

Effect of coding regions on chloroplast gene expression in Chlamydomonas reinhardtii.

An exogenous gene, placed between the 5'-upstream regions of the Chlamydomonas reinhardtii chloroplast genes, rbcL or psbA, and the 3'-end of the rbcL gene, do not have the same expression pattern as endogenous genes in the C. reinhardtii chloroplast. Here, we chose four chloroplast genes, rbcL, psbA, psbD and atpA, and examine the effects of chloroplast gene coding regions on gene expression in C.